Investigating SX-682 in Combination With Apalutamide in Metastatic Castration-resistant Prostate Cancer
Clinical trial NCT07002320 · RECRUITING
Trial details
- NCT number
- NCT07002320
- Sponsor
- Institute of Cancer Research, United Kingdom
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-28
- Primary completion
- 2029-10-01
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.